Study of CPI-100 in Patients With Advanced Tumors

NCT03781362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Tumors

Interventions

DRUG: CPI-100
DRUG: Capecitabine

Sponsor

Coordination Pharmaceuticals, Inc.